Helium ion beam therapy for the treatment of cancer was one of several developed and
studied particle treatments in the 1950s, leading to clinical trials beginning in 1975 at the …

Purpose: In-vivo range verification has been a hot topic in particle therapy since two
decades. Many efforts have been done for proton therapy, while fewer studies were …

Proton and ion beam therapy has proven to benefit tumour control with lower side-effects,
mostly in paediatrics. Here we demonstrate a feasible technique for proton and ion beam …

Real-time range verification of particle beams is important for optimal exploitation of the
tissue-sparing advantages of particle therapy. Positron Emission Tomography (PET) of the …

The physical range uncertainty limits the exploitation of the full potential of charged particle
therapy. In this work, we face this issue aiming to measure the absolute Bragg peak position …

Proton therapy of prostate cancer (PCPT) was linked with increased levels of gastrointestinal
toxicity in its early use compared to intensity-modulated radiation therapy (IMRT). The higher …

This work provides the first experimental proof of an increased neutron capture photon
signal following the introduction of boron to a PMMA phantom during helium and carbon ion …

Tracking of single particles accelerated by synchrotrons is a subject that crosses several
physics fields. The high clinical intensities used in particle therapy that can exceed 109 p/s …

Accurate in-vivo verification of beam range and dose distribution is crucial for the safety and
effectiveness of particle therapy. Prompt gamma (PG) imaging, as a method for real-time …

Helium ion beam therapy, one of the particle therapies developed and studied in the 1950s
for cancer treatment, resulted in clinical trials starting at Lawrence Berkeley National …